Sliwkowski Mark X,Berry Leanne,Phillips Gail Lewis
申请号：
NZ70929309
公开号：
NZ709293A
申请日:
2009.03.10
申请国别(地区):
NZ
年份:
2017
代理人:
摘要：
Disclosed is a therapeutic combination for the treatment of hyperproliferative disorders/breast cancer, comprising trastuzumab-MCC-DM1 and lapatinib, wherein the combination of the two provides a synergistic effect
